Nesina (alogliptin)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Nesina (alogliptin), covering 2011-09-27 to 2014-04-15. Get the full timeline:
Most recent: Clinical Trial Update: Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome [Phase 3]